Piper Jaffray Downgrades Inovio Pharmaceuticals (INO) to Neutral

March 16, 2017 2:53 AM

Piper Jaffray downgraded Inovio Pharmaceuticals (NASDAQ: INO) from Overweight to Neutral with a price target of $9.00 (from $13.00).Analyst Dr ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found